• Skip to main content
  • Blog
  • Contact Us
  • CALL NOW
    24 HOURS
  • 303-420-TOURS
Colorado Cannabis Tours 420 Logo
  • Cannabis Tours
  • 420-Friendly Hotels
    • Denver 420 Friendly Hotels
    • California Hotels
    • Las Vegas Hotels
  • Activities & Classes
  • Services
  • Packages
  • Special Events
    • 4/20 Events
    • Winter Holiday Events
  • The 420 Blog
  • Contact Us
  • Home
Stay High Blog

Is the DEA about reschedule (or deschedule) marijuana?

Thursday July 07, 2016

back to latest post list

 

In April this year, the Drug Enforcement Administration released a memo regarding the potential rescheduling of cannabis. Substances listed as Schedule I are considered to have no medical value and cannabis has been denoted as such since 1970. But what does that mean? And while a rescheduling of the plant would be an absolute admission by the DEA that they’ve been wrong all these years and that marijuana does have medical properties, it could also come along with a host of not so great repercussions.

 

Drug schedules are a product of the Drug Enforcement Administration. There are 5 schedules in total and they are used to split up and classify substances based their acceptable medicinal uses and their potential to be abused. Schedule I is the most regulated and Schedule V is at the other end of the spectrum. The more a drug is abused by the population, the more dangerous it is considered to be and the more likely it is to become a Schedule I drug. The more severe the physical and/or psychological dependence on a substance is, the more likely it is to become a Schedule I drug.

 

A few examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote. Cannabis seems pretty tame in comparison, right?

CCT DEA Schedule of Drugs
DEA Schedule of Drugs

 

Historically, Schedule I drugs have been nearly impossible to research because they are considered to have absolutely no medical properties whatsoever. So why research them? What good are they to science? But that is not the only reason cannabis research is effectively blocked. In order to do any federally recognized research on cannabis, you currently need to obtain any marijuana used in your research from one lonely garden run by the government. Which sounds like quite an unnecessary burden for scientists. There was an application once, only once, by a researcher named Lyle Craker, who wanted to grow cannabis in bulk to supply research material for interested scientists. It was denied. Surprise. And the appeal was denied. Surprise, surprise.

 

If rescheduled, there would be a much greater opportunity for studies utilizing cannabis to be conducted. With more studies come more information and with more information comes a better chance of understanding the full potential of marijuana as a medicine.

 

And let’s get real, information is power, and we are robbing ourselves of a whole lot of power by not trying to get the total picture when it comes to the makeup, classification, uses and medical properties of cannabis. Congressman and cannabis activist Jared Polis agrees, “I think it’s just common sense to allow good science to be done.” A Democrat from Colorado, Polis has advocated for years for the DEA to lighten up when it comes to pot.

 

The rescheduling could also eliminate a massive headache for cannabis businesses. As it stands, certain tax restrictions affecting businesses that deal in Schedule I or Schedule II drugs. The 280E provision prevents businesses in the cannabis industry from deducting almost all business expenses that non cannabis companies are allowed to claim. This puts an unnecessary burden on legal businesses. It’s an unofficial tax that all cannabis businesses have to account for, and one that takes money out of the pockets of hardworking individuals – from growers and budtenders to owners and CEOs.

 

The DEA reconsiders classifications for scheduled substances routinely enough that marijuana not having been seriously reevaluated more than a handful of times in the last 45 years is a little shocking and a lot disappointing for many in the cannabis community and beyond. It also makes it really hard to take the schedules seriously when they have ignored such a glaring miscalculation in their regulations. Marijuana, without a doubt, has medicinal values and has been proving as much for as long as it’s been labeled otherwise. It’s time for a move off of Schedule I, definitely.

 

But it won’t be all positive news if cannabis goes through a rescheduling process. Many activists are campaigning for a complete and total descheduling of the cannabis plant. They say that the risks of negatively affecting the currently regulated medical marijuana are too great to move forward with a rescheduling.

 

For one thing, if cannabis is rescheduled, there is every possibility that it will signal the entrance of seriously big business in the medical marijuana industry. There are definitely large companies that exist in the marijuana field, but none as large as Marlboro. How would smaller dispensaries or grows ever compete with a company with billions of dollars at their disposal?

 

Additionally, moving cannabis from one schedule to another is going to turn the current industry upside down, even if big business doesn’t get involved (but that isn’t likely to be the case). A recent story by Rolling Stone examined the potential promises and pitfalls of rescheduling marijuana and prophesied a thing or two,

 

“If the federal government determines that medical marijuana must be subjected to FDA approval, companies would have to enter a process that can take years to complete and cost more than $1 billion per product. Few, if any, cannabis companies in the U.S. have the resources for that, which might open the door for Big Pharma to muscle in and take over the business.”

 

A full descheduling however, could roll out similarly to the way descheduling of tobacco and alcohol did, and allow currently functioning businesses to transition in a more productive and fiscally responsible way.

 

Although a date of ruling has not been made clear by the DEA, they have conceded that they’ve received the necessary recommendation from the Food and Drug Administration, or FDA. And even though the DEA stated it  “understands the widespread interest in the prompt resolution of these petitions” and hoped to have a decision within the first half of 2016, here we are, already in the second half of 2016, not any closer to knowing the fate in store for cannabis.

 

The actual repercussions of a rescheduling or descheduling of cannabis remain hazy at best. One thing is clear however,  it does not belong on Schedule I. Changing the way the DEA has classified cannabis for the past 45 years would go a long way in legitimizing the cannabis plant and community for the next 45 years and beyond.

  • Author
  • Recent Posts
Brittany Driver
Brittany Driver
Brittany Driver, a native Texan, lives in Denver with her husband and toddler. She writes for Colorado Cannabis Tours, The Cannabist, The Denver Post, and was featured in documentary Rolling Papers. She is passionate about Pot and Parenting.
Brittany Driver
Latest posts by Brittany Driver (see all)
  • Doctor’s Orders - November 16, 2017
  • Big Pharma Takes on Pot Painkillers - July 31, 2017
  • Nicolas Trainerbees - July 13, 2017

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Check us out on Google Plus Engage our tweets on Twitter See our snaps on Instagram Follow our story on Facebook

Categories

  • Cannabinoids (10)
  • Cannabis Culture (44)
  • Cannabis Travel (20)
  • Events (14)
  • Guides (31)
  • How-To's and FAQ's (9)
  • Legalization (27)
  • Visit Denver (22)

Browse by tags

420 budtender Cannabis Cannabis Community Cannabis culture Cannabis Cup Cannabis Hyperemesis Cannabis Industry Cannabis Jobs Cannabis Legalization cbd CHS Colorado Colorado Springs Colorado Travel Concentrates Cosmic Cannabis Culture denver dispensary Dispensary Jobs Edibles Health Health & Science Health and Wellness Hemp High Times how to Information Legalization Legal Marijuana Marijuana Marijuana Jobs Marijuana Policy Marijuana Retail Medical Marijuana Recreational Marijuana Research Science thc Things to See and Do Travel Guide vaping vaporizer Washington DC Weed
Visit our new
cannabis destinations
Visit our new cannabis friendly destinations
Cannabis Tours California Logo
Visit CannabisTours.com
Las Vegas California DC NYC FL

Questions? Call Us 24/7 at

303-420-TOURS

Send us an Email (24/7 support)

Customer Support

We’re here to help!

Open Online Chat

Colorado Cannabis Tours 420 Logo

The #1 Cannabis Themed Tourism Company

Colorado Cannabis Tours operates as an ARC accredited travel agency, educational and sightseeing tour operator and legally licensed, fully compliant luxury limousine service in partnership with our licensed limousine partners operating in the greater Denver Metropolitan area and throughout Colorado. For more information on our Company Policies.

Questions? Call Us 24/7 at

303-420-TOURS

Email us (24/7 customer support)

Connect with us!


    We never spam. We promise!

    CannabisTours.com

    Proud partners of
    CannabisTours.com

    Colorado Hotel and Lodging Association
    National Cannabis Industry Association
    Colorado Cannabis Tours BBB Business Review

    Company

    • Careers
    • Media Inquiries
    • Partner with us
    • Webmaster
    • Our Partners

    Navigation

    • Home
    • Denver Cannabis Tours
    • Denver 420 Friendly Hotels
    • 420 Friendly Ski Resort & Lodges
    • Cannabis Classes
    • Cannabis Services
    • Cannabis Tourism Packages
    • Denver 420 2023 Events (April 20th)
    • Winter Holidays Events
    • Gift Shop / Merchandise
    • Blog
    • Site Map
    Open Online Chat
    Email us (24/7 customer support)
    Cancellation, Policies & Membership
    Privacy Policy

    Get in on the newsletter


      We never spam. We promise!

      Hit us up on social!

      Partners

      Visit CannabisTours.com

      Proud partners of CannabisTours.com

      Colorado Hotel and Lodging Association
      National Cannabis Industry Association
      Colorado Cannabis Tours BBB Business Review

      Navigation

      • Home
      • Denver Cannabis Tours
      • Denver 420 Friendly Hotels
      • 420 Friendly Ski Resort & Lodges
      • Cannabis Classes
      • Cannabis Services
      • Cannabis Tourism Packages
      • Denver 420 2023 Events (April 20th)
      • Winter Holidays Events
      • Gift Shop / Merchandise
      • Blog
      • Site Map

      Company

      • Open Online Chat
      • Careers
      • Media Inquiries
      • Partner with us
      • Webmaster
      • Our Partners
      • Contact
      • Cancellation, Membership & Policies
      • Privacy Policy

      ColoradoCannabisTours.com © 2023